Brief: Sun Pharma Says Partner Philogen's Phase II Flash Study In Soft Tissue Sarcoma Did Not Meet Primary Endpoint
March 27 (Reuters) - SUN PHARMA: PARTNER PHILOGEN'S PHASE II FLASH STUDY IN SOFT TISSUE SARCOMA DID NOT MEET PRIMARY ENDPOINT PHILOGEN'S PHASE II GLIOSTAR TRIAL IN GLIOBLASTOMA DID NOT MEET PRIMARY ENDPOINT PHILOGEN REMAINS COMMITTED TO EXECUTION OF GLIOSUN CLINICAL TRIAL Source text: ID:nBSE70fvgH Further company coverage: PHIL.MI ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses